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A B S T R A C T
Background
Constipation is a functional bowel disorder that can reduce quality of life in the puerperium period. The diagnosis of postpartum
constipation is both subjective and objective. It is characterised by symptoms such as pain or discomfort, straining, hard lumpy stools
and a sense of incomplete bowel evacuation. Haemorrhoids, pain at the episiotomy site, effects of pregnancy hormones and hematinics
used in pregnancy can increase the risk of postpartum constipation. Although a high fibre diet and increased fluid intake is encouraged
to assist defecation in the puerperium, pain-relieving drugs and laxatives are common drugs of choice to alleviate constipation. However,
the effectiveness and safety of laxatives on the nursing mother need to be ascertained.
Objectives
To evaluate the effectiveness of interventions for treating postpartum constipation.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (28 March 2014), the metaRegister of Controlled
Trials, the US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov), the Australian New Zealand Clinical Trials
Registry (ANZCTR), theWorld Health Organization International Clinical Trials Registry platform (ICTRP), the ProQuest database,
StellenboschUniversity database andGoogle Scholar (28March 2014). We also searched the reference lists of potentially relevant studies
identified by the search, reviewed articles for relevant trials and contacted experts to identify any additional published or unpublished
trials (10 April 2014).
Selection criteria
All randomised controlled trials comparing any intervention for the treatment of postpartum constipation to another intervention,
placebo or no intervention.
Interventions could include laxatives, surgery, as well as educational and behavioural interventions.
Data collection and analysis
Two review authors independently screened the results of the search to select potentially relevant studies using pre-designed eligibility
inclusion criteria. Discrepancies were resolved through discussion. We did not identify any studies for inclusion.
1Interventions for treating postpartum constipation (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
We did not identify any studies that met our inclusion criteria. We excluded nine studies.
Authors’ conclusions
We could not make explicit conclusions on interventions for treating postpartum constipation because we found no studies for inclusion
in this review. Rigorous and well-conducted large randomised controlled trials aimed at treating postpartum women diagnosed with
constipation would be beneficial. These trials should also address the criteria for administering the intervention (time and stage of a
diagnosis of postpartum constipation), and the safety and effectiveness of such interventions.
P L A I N L A N G U A G E S U M M A R Y
Interventions for treating postpartum constipation
Women may experience constipation during the postpartum period. Consipation is defined as a functional bowel disorder that is
characterised by pain and discomfort, straining, hard lumpy stools and a sense of incomplete bowel evacuation. Haemorrhoids, pain at
the episiotomy site, effects of pregnancy hormones and iron supplementation can increase the risk of postpartum constipation; as can
damage to the anal sphincter or pelvic floor muscles during childbirth. It is a source of concern to the new mother who is recovering
from the stress of delivery. The discomfort does not only affect the mother’s health, but also impacts on the new baby’s well-being,
since it needs most of the mother’s attention at this time.
A high fibre diet and increased fluid intake can prevent constipation in the puerperium period. Pain-relieving drugs and laxatives are
common drugs in relieving constipation. Laxatives are grouped according to their function, as bulk-forming laxatives (such as bran,
psyllium and methycellulose) that increase the weight and water content of the stool to facilitate bowel movement; osmotic laxatives
(such as lactulose and polyethylene glycol (PEG)) that add water to the colon to improve bowel movement; and stimulant laxatives
(such as bisacodyl, castor oil and senna), which act by irritating the intestinal wall. Stool softeners lubricate stools to improve their
passage.
This review aimed to evaluate the effectiveness and safety of the available interventions to treat postpartum constipation. We did not
find any randomised controlled trials where women diagnosed with postpartum constipation were treated with different interventions.
We are thus unable to make any conclusions. There is a need for large trials to evaluate the effectiveness and safety of interventions
(such as laxatives, surgery, as well as educational and behavioural interventions) during the postpartum period.
B A C K G R O U N D
Description of the condition
Postpartumconstipation is a common condition affecting postpar-
tum mothers (Cheng 2008). Traditionally, the postpartum period
starts from childbirth and includes the following six weeks during
which the mother’s body returns to the pre-pregnant state (Liu
2009). Evidence from studies however, suggests that a great num-
ber of women experience constipation up to three to six months
postpartum and in some individuals it may even persist to 12
months following delivery (van Brummen 2006). Constipation
can be defined as difficult bowel evacuation characterised by strain-
ing, lumpy or hard and dry stools, sensation of incomplete evac-
uation, anorectal obstruction, or the use of manual manoeuvres
(Higgins 2004). According to the Rome III criteria (Drossman
2006), chronic functional constipation in adults is defined as hav-
ing two or more of the following symptoms for at least three
months: straining in at least 25% of defecations, lumpy or hard
stools in at least 25% of defecations, sensation of incomplete evac-
uation in at least 25% of defecations, sensation of anorectal ob-
struction or blockade in at least 25% of defecations, the use of
manual manoeuvres (e.g. digital evacuation, support of the pelvic
floor) to facilitate at least 25% of defecations, fewer than three
defecations per week; loose stools are rarely present without the
use of laxative (Lee-Robichaud 2011). Since the pelvic floor mus-
cles play an important role in defecation, injury to the levator ani
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muscle during childbirth may lead to constipation in the post-
partum period (Shafik 2002). Other studies found that forceps
delivery, prolonged second stage of labour and higher child birth-
weight could result in anal sphincter injury resulting in postpar-
tum constipation (Sultan 1993). Haemorrhoids are also a com-
mon anorectal medical condition in pregnancy and the postpar-
tum period causing painful defecation and swelling at the anus
resulting in constipation. Some other specific postpartum factors
such as breastfeeding and obstetric events seem to affect bowel
function during the postpartum period (Bradley 2007).
The prevalence of postpartum constipation was estimated to be
24% at three months postpartum by Bradley 2007. The same
study found that constipation (as classified by the Rome II cri-
teria Drossman 2000), affects up to 25% of women throughout
pregnancy and at threemonths postpartum. Another study (Ponce
2008) reports a prevalence of constipation in the puerperium as
41.8% by self-report and 24.7% as classified by the Rome II cri-
teria (Drossman 2000). Defecation symptoms in early pregnancy
(12 weeks’ gestation) in women with a lower body mass index
(BMI) was also found to be associated with constipation at 12
months after childbirth (van Brummen 2006).
Constipation is a functional bowel disorder and can significantly
reduce the quality of life in adults (Daisy 2002). Postpartum con-
stipation is identifiedmostly by symptoms such as pain or discom-
fort and bowel habits and stool characteristics, which makes the
diagnosis both subjective and objective. Therefore, the use of time
transit (Bristol Stool Form Scale) and Rome criteria is necessary
for clinical diagnosis, evidence-based management and research
(Longstreth 2006). The causes of constipation can be classified as
lifestyle-related, disease-related, or drug-induced (Candy 2011).
Description of the intervention and how the
intervention might work
Appropriate interventions for the treatment of constipation de-
pend on the cause (Candy 2011). Although interventions specifi-
cally tailored for postpartum constipation treatment are few, some
of the interventions targeting constipation in general can also
be used to treat postpartum constipation. Lifestyle modifications
that include adequate fibre (such as fruits, vegetables, for exam-
ple cucumber, and soup) (Liu 2009) and water and fluids (Candy
2011) in the diet can help to relieve the symptoms and prevent
recurrences of constipation. Soluble fibre (which helps soften the
stools) and insoluble fibre (which adds bulk to the stools) both
promote regular bowel movements (Balch 2010). Laxatives can
be used to treat constipation and are grouped in the following
categories according to their function: bulk-forming laxatives, os-
motic laxatives, stimulant laxatives, faecal softeners and lubricants
(Candy 2011). Bulk-forming laxatives (such as bran, psyllium, and
methylcellulose) work by increasing the weight and water con-
tent of the stools and thereby facilitate the peristaltic movement
of stools (Balch 2010). Osmotic laxatives (such as lactulose and
polyethylene glycol (PEG)) add water into the colon, which then
improves bowel movement (NIH 2007). A recent Cochrane re-
view reported the treatment effect of two osmotic laxatives (lac-
tulose versus PEG) for chronic constipation and concluded that
PEG is superior to lactulose in improving the form and frequency
of the stool, relieving abdominal pain, and in decreasing the need
for additional products (Lee-Robichaud 2011). Stimulant laxa-
tives (such as bisacodyl, castor oil, and senna) ease the bowel move-
ment by irritating the intestinal wall (Balch 2010). Stool soften-
ers work by lubricating stools, thereby improving the passage of
stools through the intestines (NIH 2007). Surgical interventions
can also be used to treat constipation, for example, surgical repair
of anorectal problems such as rectal prolapse (NIH 2007). Stud-
ies have also reported on the efficacy of acupuncture and Chinese
herbal medicine as an intervention in treating postpartum consti-
pation (Cheng 2009). A randomised controlled trial (Eogan 2007)
found that administration of a stool-bulking agent in addition to a
laxative is not more effective in preventing constipation during the
postpartum period for women who have sustained anal sphincter
injury at vaginal delivery.
Why it is important to do this review
The postpartumperiod is an important stage in amother’s life, and
for her newborn baby. Considering themorbidity effects of consti-
pation, cost and negative impact on quality of life (Peppas 2008),
an evaluation of the effectiveness and safety of available interven-
tions for the treatment of postpartum constipation is necessary.
Although a number of systematic reviews on constipation have
been published (for example, Gordon 2011; Higgins 2004; Jewell
2001; Lee-Robichaud 2011;Mugie 2011; Peppas 2008), currently
there is no systematic review published on interventions for the
treatment of postpartum constipation specifically. Although there
are some interventions for the treatment of general constipation,
not all of them are suitable for use in the postpartum period. Fur-
thermore, cultural beliefs about the postpartum period may result
in some lifestyles with certain prescribed diets and lack of exercise,
both of which may promote postpartum constipation (Liu 2009).
A systematic review is therefore necessary to summarise and eval-
uate the effectiveness and safety of various interventions for the
treatment of postpartum constipation.
O B J E C T I V E S
To evaluate the effectiveness and safety of interventions for the
treatment of postpartum constipation.
M E T H O D S
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Criteria for considering studies for this review
Types of studies
All randomised controlled trials (including those using a cluster-
randomised design) comparing any intervention for the treatment
of postpartum constipation versus another intervention or placebo
or no treatment were eligible for inclusion. Studies presented only
as abstracts were eligible for inclusion. Studies using a cross-over
design were not eligible for inclusion because the physiological
condition of women during the first month postpartummight not
be the same as six months after childbirth.
Types of participants
Postpartum women (from day one to six months postpartum) di-
agnosed with postpartum constipation (using pre-specified crite-
ria (Rome and Bristol Stool Form Scale) and self-report). We also
planned to include postpartum women with co-morbidities, e.g.
sphincter injuries.
The six months criterion was used because constipation is a prob-
lem that may last longer than six weeks following delivery, which
is the usual postpartum period.
Types of interventions
Intervention
Any intervention for the treatment of postpartum constipation
including laxatives, surgery, as well as educational and behavioural
interventions.
Control
Any other intervention for the treatment of postpartum constipa-
tion, or placebo or no treatment.
Types of outcome measures
Primary outcomes
1. Pain or straining on defecation.
2. Participant-reported relief of constipation symptoms.
3. Stool frequency.
Secondary outcomes
1. Stool consistency (e.g. Bristol Stool Scale): The Bristol
Stool Form Scale is a formal research tool used to evaluate the
effectiveness of treatments for gastrointestinal tract disease as
well as in clinical communication. It assists the patients to report
on stool consistency. It is used to categorise stool into seven types
according to stool consistency (Lewis 1997).
2. Use of additional products (e.g. alternative laxative agents,
enemas).
3. Relief of abdominal pain.
4. Change in quality of life.
5. Adverse effects caused by the intervention, including:
◦ nausea or vomiting;
◦ pain;
◦ flatus;
◦ diarrhoea;
◦ faecal incontinence.
Search methods for identification of studies
Electronic searches
We contacted the Trials Search Co-ordinator to search the
Cochrane Pregnancy and Childbirth Group’s Trials Register (28
March 2014).
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. weekly searches of Embase;
4. handsearches of 30 journals and the proceedings of major
conferences;
5. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE and
Embase, the list of handsearched journals and conference pro-
ceedings, and the list of journals reviewed via the current aware-
ness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
In addition,we searched the following (28March 2014) to identify
relevant trials:
• The metaRegister of Controlled Trials.
• The US National Institutes of Health Ongoing Trials
Register (www.clinicaltrials.gov).
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• The Australian New Zealand Clinical Trials Registry (
ANZCTR).
• The World Health Organization International Clinical
Trials Registry platform (ICTRP).
We also searched the ProQuest database, Stellenbosch University
database and Google scholar (28 March 2014). See Appendix 1
for search terms used.
Searching other resources
Reference lists and correspondence
We searched the reference lists of potentially relevant studies iden-
tified by the search and reviewed articles for relevant trials. We
also contacted experts in the field of constipation and obstetrics
to identify any additional published or unpublished trials.
We did not apply any date or language restrictions.
Data collection and analysis
The methods of data collection and analysis are based on the stan-
dard methods text of the Cochrane Pregnancy and Childbirth
Group.
Selection of studies
Two review authors, Eunice Turawa (ET) and Alfred Musekiwa
(AM), independently screened the results of the search to select
potentially relevant studies. Applying eligibility criteria using a
pre-designed eligibility form based on the inclusion criteria, we ex-
cluded duplicates and studies that were not relevant to the review.
We retrieved the full-text articles of potentially relevant studies.
Each of the articles was scrutinised to ensure that multiple publi-
cations of the same trial were included only once.Where eligibility
was unclear, we sought clarification from the trial authors and re-
assessed the corresponding articles. We resolved any disagreement
through discussion and consultation with the third review author
(Anke Rohwer (AR)). We excluded studies that did not meet the
inclusion criteria and stated the reasons in the Characteristics of
excluded studies table.
Data extraction and management
We did not identify any studies that met our inclusion criteria and
thus were unable to perform data extraction and analysis. We have
outlined the methods to be used in future updates of this review
in Appendix 2 and Appendix 3.
R E S U L T S
Description of studies
Characteristics of excluded studies.
Results of the search
We summarised the search results in detail in Figure 1. The
Cochrane Pregnancy and Childbirth Group’s Trials Register re-
trieved 11 trial reports; Stellenbosch University database, one re-
port; Google Scholar, 11,500 reports, Clinical Trials Registries,
two reports; screening study references yielded one extra trial mak-
ing a total of 11,515 trial reports. After deduplication, we screened
11,501 reports resulting in nine potentially relevant reports.
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Figure 1. Study flow diagram
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Scrutinising the full texts of the remaining nine trials (two non-
English studies inclusive) resulted in none of the trials meet-
ing our eligibility criteria. Nine trials (Du 2008; Duncan 1957;
Diamond 1968; Goplerud 1967; Mundow 1975; Nardulli 1995;
Raatikainen 1974; Shelton 1980; Zuspan 1960) were excluded for
the reasons displayed in the Characteristics of excluded studies.
Included studies
We could not include any trials because none of the trials met the
pre-specified inclusion criteria.
Excluded studies
We excluded nine trials (Du 2008; Duncan 1957;Diamond 1968;
Goplerud 1967; Mundow 1975; Nardulli 1995; Raatikainen
1974; Shelton 1980; Zuspan 1960).The most common reason
for exclusion was that study design was not randomised trial (Du
2008; Duncan 1957; Goplerud 1967; Mundow 1975; Nardulli
1995; Raatikainen 1974; Zuspan 1960). For Diamond 1968
and Shelton 1980, the participants were not clinically diagnosed
with postpartum constipation. See the Characteristics of excluded
studies.
Risk of bias in included studies
There are no included studies.
Effects of interventions
There are no included studies in this review.
D I S C U S S I O N
Summary of main results
There are no included studies in this review.
The objective of this review was to assess the effectiveness and
safety of different forms of interventions for treating postpartum
constipation. A comprehensive electronic search without language
restrictions of potential trials was conducted and nine trial re-
ports identified. However, we did not find any trials of postpartum
women clinically diagnosed with constipation and subsequently
treated for constipation. We therefore excluded all nine studies.
Potential biases in the review process
We sought published and unpublished trials irrespective of lan-
guages. Translators were involved to assist in studies published in
foreign languages. At least two review authors independently as-
sessed trials for inclusion in the review.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The available trials did not meet this review’s pre-specified inclu-
sion criteria. Therefore, we cannot make any conclusions on the
effectiveness and safety of interventions for the treatment of post-
partum constipation.
Implications for research
We did not identify any studies evaluating treatment of postpar-
tum constipation on the following outcomes: pain or straining
on defecation; participant-reported relief of constipation symp-
toms, stool frequency (using Bristol scale); use of additional prod-
ucts (e.g. alternative laxative agents, enemas); change in quality of
life and adverse effects caused by the intervention such as, nausea
or vomiting, pain and flatus. Rigorous and well-conducted large
randomised controlled trials of high quality would be beneficial
to address the criteria to assess the need for laxatives, time and
stage when diagnosis of postpartum constipation can be made,
assessment of effectiveness and safety of interventions for preven-
tion and treatment of postpartum constipation. Trials exploring
educational and behavioural interventions in treating postpartum
constipation would also be beneficial.
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As part of the pre-publication editorial process, this review has
been commented on by three peers (an editor and two referees
who are external to the editorial team), a member of the Pregnancy
and Childbirth Group’s international panel of consumers and the
Group’s Statistical Adviser.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Diamond 1968 Participants not diagnosed with postpartum constipation.
Du 2008 Not a randomised controlled trial.
Duncan 1957 Not a randomised controlled trial.
Goplerud 1967 Not randomised controlled trial.
Mundow 1975 Not randomised controlled trial
Nardulli 1995 Not randomised controlled trial.
Raatikainen 1974 Not a randomised controlled trial.
Shelton 1980 Participants not diagnosed with postpartum constipation.
Zuspan 1960 Not randomised controlled trial.
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. Search terms
We searched the metaRegister of Controlled Trials, the US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov),
the Australian New Zealand Clinical Trials Registry (ANZCTR), the World Health Organization International Clinical Trials Registry
platform (ICTRP), (using the terms ’constipation’ AND (’postpartum OR postnatal’)
Search method used in Stellenbosch University database:
(postnatal OR “post delivery” OR postpartum) AND (constipation OR constipat* OR hard stool*OR “impacted stool”OR “lumpy
stool”OR “rock-like stool”) AND (interventions OR treatment OR treat* OR management OR therapy)
Search method used in Google scholar search:
(postpartum OR postnatal OR “post delivery” OR “after birth”) AND (constipation OR “hard stool” OR “lumpy stool”) AND
(management OR relief OR treatment)
Appendix 2. Data Extraction Form
Review title: Interventions for treating postpartum constipation
Review ID: Study ID: Reference ID:
Person extracting data and
date:
Date of date extraction: Year of study publication:
Title:
Author: Publication type: Full text / Abstract / Book chapter/ progress
report / others
Country:
Checked by:
Study design
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Type of study design (cluster-RCT; block randomisation; stratified randomisation; multi-arm; factorial etc):
Unit of randomisation:
Participants and setting
Describe setting:
Inclusion criteria:
Exclusion criteria:
PARTICIPANTS: Postpartum women diagnosed with constipation
Intervention
Were comparison groups treated with pre-specified
Intervention in one group and control intervention in the other group?
Experimental intervention:
Type of intervention: Laxatives/Acupunctures/Educational intervention/Chinese herbs
Comparison
Type of control : Active/Placebo/Active + placebo/No therapy
OUTCOMES ASSESSED:
Definition of outcome assessed:
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(Continued)
Primary outcomes:
Secondary outcomes
Outcome not specified:
REASONS FOR EXCLUSION OFSTUDY FROM REVIEW ACCORDING TO PROTOCOL
Method No RCT / Other
Participant related Not postpartum women
Outcomes
Others: Duplication, etc
TRIAL CHARACTERISTICS
Sample size : Study design:
No. randomised: No. excluded: Funding:
Recruitment
method :
Length of follow-up = from ---- to ----- Conflict of interest statement:
No. of drop-outs =
Reasons for drop-out
NR
Loss to follow-up symmetric in both arms?
Study methods
Risk of bias
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Domain Judgement Quote /Comments
Adequate random sequence
generation:
Was the allocation sequence ad-
equately generated?
Low High Unclear
Allocation concealment
Was allocation concealment ad-
equate?
Low High Unclear
Performance Bias
Blinding of participants/
Providers
Was knowledge of the allo-
cated intervention adequately
prevented during the study?
Low High Unclear
Detection Bias
Blinding of outcome assessors
Was knowledge of the allocated
interventions adequately pre-
vented during measurement?
Low High Unclear
Attrition Bias
Low High Unclear
Com-
plete outcome data addressed
Were incomplete outcome data
adequately addressed?
Low High Un-
clear
Reporting bias
Free of selective reporting
Are reports of the study free of
suggestion of selective outcome
reporting?
Low High Un-
clear
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(Continued)
Other Bias
Free of other bias
Was the study apparently free of
other problems that could put
it at a high risk of bias?
Low High Unclear
Number of participants entering trial
15% or fewer excluded
More than 15% excluded
Analysed as ‘intention-to-treat’
Unclear
ADDITIONAL INFORMATIONS
Were withdrawals described? Low High Unclear
Discuss if appropriate…………………………………………………………………………………
Outcomes for main analysis
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Outcome Measures
(Dichotomous)
Total number of participants in study =
Intervention group
Total no. in study =
Control group
Total no. in study =
events total events total
Primary:
1
2
Secondary:
3
4
5
Outcome Measures
(Continuous)
Total number of participants in study =
Intervention group
Total no. in study =
Control group
Total no. in study =
total mean SD total mean SD
Primary:
1
2
Secondary:
3
4 I I
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(Continued)
5 I I
Outcomes for subgroup analyses
Outcome Measures
(Dichotomous)
Total number of participants in study =
Intervention group
Total no. in study =
Control group
Total no. in study =
events total events total
Primary:
1
2
Secondary:
3
4
5
Outcome
Measures
(Continuous)
Unit of measure-
ment
Total number of participants in study =
Intervention group
Total no. in study =
Control group
Total no. in study =
total mean SD total mean SD
Primary:
1
2
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(Continued)
Secondary:
3
4 I
5 I I
General conclusions
Very brief summary of study authors main findings/conclusions:
Notes
Exclusion after data extraction
Reasons for exclusion: (study design? participants? interventions/ outcomes? attrition? bias?)
Dates:
Date entered into RevMan and by whom?
Date checked and by whom?
Date copy sent to editorial base and by whom?
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Appendix 3. Data collection and analysis (for future updates of this review)
Data collection and analysis
Selection of studies
Two review authors, Eunice Turawa (ET) and Alfred Musekiwa (AM), will independently screen the results of the search to select
potentially relevant studies and apply eligibility criteria using a pre-designed eligibility form based on the inclusion criteria. Corre-
sponding full-text articles will be retrieved and used in applying the eligibility criteria. Each of the articles will be scrutinised to ensure
that multiple publications of the same trial will be included only once. If eligibility is unclear, we will seek clarification from the trial
authors and re-assess the corresponding articles. We will resolve any disagreement through discussion. We will exclude studies that do
not meet the inclusion criteria and state the reasons in the ’Characteristics of excluded studies’ table.
Data extraction and management
Using a specially designed pre-piloted data extraction form, two review authors (ET and AM) will independently extract information
on methods, participants, interventions and outcomes from each included study. The following information will be extracted:
• author, year of publication, country of origin, journal citation, and language;
• study methods (trial design, duration, risk of bias, setting, study inclusion criteria);
• participants (number, age, source, inclusion and exclusion criteria, duration of symptoms, previous treatments, underlying
conditions, drop-outs/withdrawals);
• interventions (type, dose, duration, route of delivery, control used, run-in phase, treatment phase, follow-up);
• outcome data for each of the primary and secondary outcomes above.
For each dichotomous outcome, we will extract the number of participants experiencing the event and the number of participants
in each treatment group. For each continuous outcome, we will extract the arithmetic means, standard deviations (or information to
estimate the standard deviations), and the number of participants, in each treatment group. For continuous data, if geometric means
and their standard deviations on the log scale have been reported, we will extract them. Medians and ranges will also be extracted if
these are reported in place of means and standard deviations. We will enter data into Review Manager software (RevMan 2014) and
check for accuracy. When information regarding any of the above is unclear, we will attempt to contact the authors of the original
reports to provide further details. We will resolve discrepancies through discussion.
Assessment of risk of bias in included studies
Individually-randomised trials
Two review authors (ET and AM) will independently assess risk of bias for each included study using the criteria outlined in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). The criteria is given in Appendix 1. The domains that will be
assessed are adequate sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting and other
potential sources of bias. Each included study will be judged as ’yes’ (low risk of bias), ’no’ (high risk of bias), or ’unclear’ (uncertain
risk of bias) according to each of the six domains. The results will be summarised using the ’Risk of bias’ summary and the ’Risk of
bias’ graph in addition to the ’Risk of bias’ tables. Where clarity is required or in case of missing data, we will contact the trial authors
for clarification. We will resolve any disagreement by discussion.
Cluster-randomised trials
For cluster-randomised trials, we will assess recruitment bias, baseline imbalance, loss of clusters, incorrect analysis, and incomparability
with individually-randomised trials. (Higgins 2011).
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Measures of treatment effect
Dichotomous data
For dichotomous data, we will present results as summary risk ratio with 95% confidence intervals.
Continuous data
For continuous data, we will use the mean difference if outcomes are measured in the same way between trials. We will use the
standardised mean difference to combine trials that measure the same outcome, but use different methods. In either case, corresponding
95% confidence intervals will also be presented.
Unit of analysis issues
Cluster-randomised trials
We will include cluster-randomised trials in the analyses along with individually-randomised trials. We will adjust their sample sizes
using the methods described in the Cochrane Handbook for Systematic Reviews of Interventions Section 16.3.4 using an estimate of the
intracluster correlation co-efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population.
If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC.
If we identify both cluster-randomised trials and individually-randomised trials, we plan to synthesise the relevant information. We
will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction
between the effect of intervention and the choice of randomisation unit is considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit and perform a subgroup analysis to investigate the effects of the
randomisation unit.
Individually-randomised trials
Attention to the unit of analysis at the level of randomisation (individual) will be noted using the methods described in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
Multi-arm trials
When a multi-arm study contributes multiple comparisons to a particular meta-analysis, we will either combine treatment groups or
split the ‘shared’ group as appropriate and precautions will be taken to avoid the inclusion of data from the same patient more than
once in the same analysis.
Dealing with missing data
No imputation measures for missing data will be applied. Where data from the trial reports are insufficient, unclear or missing, we
will contact the trial authors by email for additional information or clarification. For included studies, we will note levels of attrition.
We will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using
sensitivity analysis. For all outcomes, we will carry out analyses, as far as possible, on an intention-to-treat basis, i.e. we will attempt to
include all participants randomised to each group in the analyses, and all participants will be analysed in the group to which they were
allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial will
be the number randomised minus any participants whose outcomes are known to be missing.
Assessment of heterogeneity
We will assess statistical heterogeneity in each meta-analysis using the T2, I2 and Chi² statistics. We will regard heterogeneity as
substantial if the I2 is greater than 30% and either the T2 is greater than zero, or there is a low P value (< 0.10) in the Chi² test for
heterogeneity.
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Assessment of reporting biases
If there are 10 or more studies in the meta-analysis, we will investigate reporting biases (such as publication bias) using funnel plots.
We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses
to investigate it..
Data synthesis
We will carry out statistical analysis using the Review Manager software (RevMan 2014). We will use fixed-effect meta-analysis for
combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are
examining the same intervention, and the trials’ populations and methods are judged sufficiently similar. If there is clinical heterogeneity
sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we
will use random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials is considered clinically
meaningful. The random-effects summary will be treated as the average range of possible treatment effects and we will discuss the
clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not
combine trials.
If we use random-effects analyses, the results will be presented as the average treatment effect with 95% confidence intervals, and the
estimates of T2 and I2.
Subgroup analysis and investigation of heterogeneity
If we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses. We will consider whether
an overall summary is meaningful, and if it is, use random-effects meta-analysis to produce it.
We plan to carry out subgroup analyses (only on primary outcomes) with respect to:
• type of laxatives (bulk-forming laxatives versus other types of laxatives);
• study design (individually- versus cluster-randomised trials).
We will assess subgroup differences by interaction tests available within RevMan (RevMan 2014).We will report the results of subgroup
analyses quoting the χ2 statistic and P value, and the interaction test I² value.
Sensitivity analysis
Sensitivity analysis will be performed (only on primary outcomes) provided there are sufficient trials. We plan to conduct sensitivity
analysis with respect to:
• robustness of the methods used regarding allocation concealment;
• losses to follow-up;
• randomisation (randomised versus quasi-randomised);
• imputed values of intra-cluster correlations (ICC).
We will report where the analysis alters the overall treatment effect.
C O N T R I B U T I O N S O F A U T H O R S
Eunice Turawa (ET) conceived the topic and developed the protocol with the assistance of Alfred Musekiwa (AM). AM wrote the data
collection and analysis section and also assisted with the writing of the background. Anke Rohwer (AR) critically engaged with the
protocol. ET and AM assessed trials for inclusion and exclusion based on pre-specified criteria and AR gave input when discrepancies
were encountered. AR wrote various sections of the review and edited all of the version of the review. ET is the guarantor for the review.
All authors approved the final version of the review.
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D E C L A R A T I O N S O F I N T E R E S T
Eunice Turawa: none known.
Anke Rohwer: none known
Alfred Musekiwa: none known.
S O U R C E S O F S U P P O R T
Internal sources
• Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa.
• Wits Reproductive Health & HIV INstitute (WRHI), Johannesburg, South Africa.
External sources
• Effective Health Care Research Consortium, UKaid from the UK Government Department for International Development, UK.
AR is supported in part by the Effective Health Care Research Consortium, which is funded by UKaid from the UK Government
Department for International Development
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Our methods text has been updated in accordance with the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011)
and the standard methods text of the Cochrane Pregnancy and Childbirth Group.
We also modified the Types of participants section to include postpartum women with co-morbidities (e.g. sphincter injuries) and
extended the scope of postpartumperiod for this review to sixmonths post delivery because evidence shows that postpartum constipation
can extend further than six weeks after delivery (van Brummen 2006).
We extended the scope of our own additional searches by also searching the following databases: ProQuest database, Stellenbosch
University database and Google scholar for potential trials. Reference lists of potential studies and reviewed articles were searched for
relevant trials and we contacted experts in the field of constipation and obstetrics for additional published or unpublished trials. Two
authors independently screened the search output and studies that were not relevant were excluded.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Postpartum Period; Constipation [∗therapy]
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MeSH check words
Adult; Female; Humans
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